Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Cardinal Health (CAH) Share Price

Media coverage about Cardinal Health (NYSE:CAH) has been trending somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cardinal Health earned a news sentiment score of 0.15 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.7971980292369 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the media headlines that may have effected Accern’s rankings:

Shares of Cardinal Health (CAH) opened at $71.49 on Friday. The firm has a market capitalization of $21,742.25, a price-to-earnings ratio of 20.78, a PEG ratio of 1.98 and a beta of 0.85. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.52 and a current ratio of 1.06. Cardinal Health has a one year low of $54.66 and a one year high of $84.88.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The business had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The company’s revenue was up 1.9% compared to the same quarter last year. During the same period last year, the company posted $1.24 EPS. research analysts anticipate that Cardinal Health will post 5.03 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd will be given a $0.4624 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.59%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.78%.

Several analysts recently issued reports on the company. Evercore ISI assumed coverage on Cardinal Health in a report on Thursday, January 4th. They issued an “in-line” rating and a $67.00 price target on the stock. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Deutsche Bank initiated coverage on Cardinal Health in a research report on Monday, December 4th. They issued a “hold” rating and a $64.00 target price on the stock. Morgan Stanley cut Cardinal Health from an “equal weight” rating to an “underweight” rating in a research report on Monday, November 20th. Finally, Argus cut Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $72.99.

TRADEMARK VIOLATION NOTICE: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Cardinal Health (CAH) Share Price” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/13/cardinal-health-cah-given-media-impact-rating-of-0-15.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Insider Buying and Selling by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply